Logo image of CEA

CHINA EASTERN AIRLINES-ADS (CEA) Stock Fundamental Analysis

NYSE:CEA - US16937R1041 - ADR

20.09 USD
+0.5 (+2.55%)
Last: 2/2/2023, 8:04:00 PM
Fundamental Rating

1

Taking everything into account, CEA scores 1 out of 10 in our fundamental rating. CEA was compared to 22 industry peers in the Passenger Airlines industry. CEA may be in some trouble as it scores bad on both profitability and health. CEA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

CEA had negative earnings in the past year.
CEA had a negative operating cash flow in the past year.
CEA Yearly Net Income VS EBIT VS OCF VS FCFCEA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10B -10B 20B

1.2 Ratios

The profitability ratios for CEA are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CEA Yearly ROA, ROE, ROICCEA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 -10 -20

1.3 Margins

CEA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CEA Yearly Profit, Operating, Gross MarginsCEA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 -20

0

2. Health

2.1 Basic Checks

CEA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CEA has more shares outstanding
The debt/assets ratio for CEA is higher compared to a year ago.
CEA Yearly Shares OutstandingCEA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M
CEA Yearly Total Debt VS Total AssetsCEA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50B 100B 150B 200B 250B

2.2 Solvency

CEA has an Altman-Z score of -0.50. This is a bad value and indicates that CEA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.50, CEA is doing worse than 69.57% of the companies in the same industry.
A Debt/Equity ratio of 5.97 is on the high side and indicates that CEA has dependencies on debt financing.
CEA has a Debt to Equity ratio of 5.97. This is in the lower half of the industry: CEA underperforms 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.97
Debt/FCF N/A
Altman-Z -0.5
ROIC/WACCN/A
WACC7.3%
CEA Yearly LT Debt VS Equity VS FCFCEA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50B 100B

2.3 Liquidity

A Current Ratio of 0.31 indicates that CEA may have some problems paying its short term obligations.
The Current ratio of CEA (0.31) is worse than 82.61% of its industry peers.
CEA has a Quick Ratio of 0.31. This is a bad value and indicates that CEA is not financially healthy enough and could expect problems in meeting its short term obligations.
CEA has a worse Quick ratio (0.30) than 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.3
CEA Yearly Current Assets VS Current LiabilitesCEA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20B 40B 60B 80B

4

3. Growth

3.1 Past

The earnings per share for CEA have decreased strongly by -142.91% in the last year.
Looking at the last year, CEA shows a very negative growth in Revenue. The Revenue has decreased by -26.68% in the last year.
The Revenue has been decreasing by -7.39% on average over the past years.
EPS 1Y (TTM)-142.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-176.11%
Revenue 1Y (TTM)-26.68%
Revenue growth 3Y-16.41%
Revenue growth 5Y-7.39%
Sales Q2Q%-7.28%

3.2 Future

Based on estimates for the next years, CEA will show a very strong growth in Earnings Per Share. The EPS will grow by 33.64% on average per year.
The Revenue is expected to grow by 24.98% on average over the next years. This is a very strong growth
EPS Next Y-90.09%
EPS Next 2Y38.13%
EPS Next 3Y33.64%
EPS Next 5YN/A
Revenue Next Year-28.49%
Revenue Next 2Y21.79%
Revenue Next 3Y24.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CEA Yearly Revenue VS EstimatesCEA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B
CEA Yearly EPS VS EstimatesCEA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CEA. In the last year negative earnings were reported.
Also next year CEA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CEA Price Earnings VS Forward Price EarningsCEA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CEA Per share dataCEA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

CEA's earnings are expected to grow with 33.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.13%
EPS Next 3Y33.64%

0

5. Dividend

5.1 Amount

CEA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHINA EASTERN AIRLINES-ADS

NYSE:CEA (2/2/2023, 8:04:00 PM)

20.09

+0.5 (+2.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)10-30 2022-10-30/dmh
Earnings (Next)03-31 2023-03-31/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.96B
Analysts77.78
Price Target22.32 (11.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-15.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.96%
Min EPS beat(2)-161.05%
Max EPS beat(2)-38.88%
EPS beat(4)1
Avg EPS beat(4)-51.86%
Min EPS beat(4)-161.05%
Max EPS beat(4)23.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-24.54%
Min Revenue beat(2)-41.9%
Max Revenue beat(2)-7.19%
Revenue beat(4)1
Avg Revenue beat(4)-12.01%
Min Revenue beat(4)-41.9%
Max Revenue beat(4)6.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.48%
PT rev (3m)14.18%
EPS NQ rev (1m)-41.49%
EPS NQ rev (3m)-41.49%
EPS NY rev (1m)15.33%
EPS NY rev (3m)-11.21%
Revenue NQ rev (1m)-17.98%
Revenue NQ rev (3m)-17.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.21
P/FCF N/A
P/OCF N/A
P/B 2.61
P/tB 5.19
EV/EBITDA N/A
EPS(TTM)-10.57
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-4.98
FCFYN/A
OCF(TTM)-2.43
OCFYN/A
SpS16.62
BVpS7.69
TBVpS3.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 5.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.3
Altman-Z -0.5
F-Score3
WACC7.3%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-142.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-176.11%
EPS Next Y-90.09%
EPS Next 2Y38.13%
EPS Next 3Y33.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.68%
Revenue growth 3Y-16.41%
Revenue growth 5Y-7.39%
Sales Q2Q%-7.28%
Revenue Next Year-28.49%
Revenue Next 2Y21.79%
Revenue Next 3Y24.98%
Revenue Next 5YN/A
EBIT growth 1Y-130.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.78%
EBIT Next 3Y64.38%
EBIT Next 5YN/A
FCF growth 1Y-337.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-188.39%
OCF growth 3Y-36.6%
OCF growth 5Y-25.55%